Payment overview · 2025
General Payments
$19.38
1 reported records · 1 companies
Healthcare provider profile · identity verified
Todd Love, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · PLYMOUTH, MN · NPI 1144296831
Verified facts
What the public records show
CMS Open Payments records show Todd Love, M.D. received $19.38 in general payments during 2025 across 1 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $19.38 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.38 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $19.38 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1518 | 425 |
| Lisinopril | Lisinopril | 818 | 236 |
| Amlodipine Besylate | Amlodipine Besylate | 749 | 215 |
| Metoprolol Succinate | Metoprolol Succinate | 613 | 185 |
| Losartan Potassium | Losartan Potassium | 520 | 140 |
| Tamsulosin Hcl | Tamsulosin Hcl | 488 | 146 |
| Levothyroxine Sodium | Levothyroxine Sodium | 445 | 118 |
| Omeprazole | Omeprazole | 425 | 123 |
| Hydrochlorothiazide | Hydrochlorothiazide | 383 | 109 |
| Metformin Hcl Er | Metformin Hcl | 341 | 95 |
| Simvastatin | Simvastatin | 337 | 95 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 232 | 81 |
| Gabapentin | Gabapentin | 205 | 74 |
| Eliquis | Apixaban | 190 | 57 |
| Furosemide | Furosemide | 189 | 68 |
| Metformin Hcl | Metformin Hcl | 186 | 58 |
| Allopurinol | Allopurinol | 184 | 52 |
| Trazodone Hcl | Trazodone Hcl | 178 | 57 |
| Sertraline Hcl | Sertraline Hcl | 176 | 58 |
| Finasteride | Finasteride | 165 | 52 |
| Metoprolol Tartrate | Metoprolol Tartrate | 162 | 49 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 161 | 74 |
| Clopidogrel | Clopidogrel Bisulfate | 146 | 47 |
| Warfarin Sodium | Warfarin Sodium | 145 | 39 |
| Potassium Chloride | Potassium Chloride | 135 | 44 |
| Carvedilol | Carvedilol | 126 | 35 |
| Alendronate Sodium | Alendronate Sodium | 115 | 38 |
| Jardiance | Empagliflozin | 109 | 38 |
| Pantoprazole Sodium | Pantoprazole Sodium | 99 | 34 |
| Atenolol | Atenolol | 97 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 97 | 39 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 78 | 45 |
| Spironolactone | Spironolactone | 76 | 24 |
| Xarelto | Rivaroxaban | 75 | 22 |
| Ozempic | Semaglutide | 73 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 69 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 68 | 19 |
| Klor-Con M20 | Potassium Chloride | 67 | 28 |
| Pravastatin Sodium | Pravastatin Sodium | 64 | 17 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 64 | 20 |
| Donepezil Hcl | Donepezil Hcl | 61 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 60 | 22 |
| Montelukast Sodium | Montelukast Sodium | 58 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 57 | 19 |
| Nitroglycerin | Nitroglycerin | 57 | 44 |
| Sumatriptan Succinate | Sumatriptan Succinate | 57 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 55 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 53 | 20 |
| Prednisone | Prednisone | 53 | 41 |
| Famotidine | Famotidine | 52 | 21 |
| Irbesartan | Irbesartan | 51 | 11 |
| Cephalexin | Cephalexin | 50 | 41 |
| Mirtazapine | Mirtazapine | 48 | 16 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 47 | 18 |
| Pregabalin | Pregabalin | 47 | 13 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 46 | 14 |
| Torsemide | Torsemide | 45 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 41 | 23 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 41 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 40 | 14 |
| Ventolin Hfa | Albuterol Sulfate | 40 | 23 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 39 | 18 |
| Glipizide | Glipizide | 39 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 36 | 11 |
| Bupropion Xl | Bupropion Hcl | 35 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 34 | suppressed |
| Lovastatin | Lovastatin | 34 | suppressed |
| Mounjaro | Tirzepatide | 34 | suppressed |
| Myrbetriq | Mirabegron | 33 | suppressed |
| Ezetimibe | Ezetimibe | 32 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 30 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 29 | 18 |
| Rybelsus | Semaglutide | 29 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 29 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 28 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 27 | suppressed |
| Methocarbamol | Methocarbamol | 27 | suppressed |
| Acyclovir | Acyclovir | 25 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 25 | suppressed |
| Ketoconazole | Ketoconazole | 25 | 15 |
| Amitriptyline Hcl | Amitriptyline Hcl | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 24 | 11 |
| Farxiga | Dapagliflozin Propanediol | 24 | suppressed |
| Azithromycin | Azithromycin | 23 | 22 |
| Buspirone Hcl | Buspirone Hcl | 23 | suppressed |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 22 | suppressed |
| Trulicity | Dulaglutide | 22 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 21 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 20 | suppressed |
| Amoxicillin | Amoxicillin | 20 | 13 |
| Clonazepam | Clonazepam | 20 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 20 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 20 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 14 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Cilostazol | Cilostazol | 19 | suppressed |
| Qvar Redihaler | Beclomethasone Dipropionate | 19 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 19 | suppressed |
| Glipizide Er | Glipizide | 18 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 18 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 18 | 16 |
| Alprazolam | Alprazolam | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Lorazepam | Lorazepam | 17 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 16 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 16 | suppressed |
| Januvia | Sitagliptin Phosphate | 16 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 16 | suppressed |
| Cefdinir | Cefdinir | 15 | 15 |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 15 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Omnipod Dash Pods (Gen 4) | Insulin Pump Cart,cont Inf,bt | 15 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 15 | suppressed |
| Dutasteride | Dutasteride | 14 | suppressed |
| Topiramate | Topiramate | 14 | suppressed |
| Bicalutamide | Bicalutamide | 13 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Dipyridamole | Dipyridamole | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Indomethacin | Indomethacin | 13 | suppressed |
| Klor-Con | Potassium Chloride | 13 | suppressed |
| Memantine Hcl | Memantine Hcl | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Baclofen | Baclofen | 12 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Glimepiride | Glimepiride | 12 | suppressed |
| Insulin Lispro | Insulin Lispro | 12 | suppressed |
| Jantoven | Warfarin Sodium | 12 | suppressed |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine Dimesylate | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Digoxin | Digoxin | 11 | suppressed |
| Epinephrine | Epinephrine | 11 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $19.38 · 1 records | Abbott Laboratories | FREESTYLE LIBRE 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error